Research location
Leiden
South Holland, Netherlands
Advertisement
Research activity in Leiden
South Holland, NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 61 trials and 65 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Leiden
61 linked trials · page 1 of 2Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceNCT07636148 · 2026-07-01 · 1 site observation
RECRUITING
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)NCT07554339 · 2026-06-18 · 1 site observation
RECRUITING
Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert OpinionsNCT07498738 · 2026-03-13 · 1 site observation
RECRUITING
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)NCT07252739 · 2025-12-19 · 1 site observation
RECRUITING
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerNCT07155187 · 2025-12-10 · 1 site observation
RECRUITING
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)NCT07216066 · 2025-12-05 · 1 site observation
RECRUITING
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsNCT06618287 · 2025-02-04 · 1 site observation
RECRUITING
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%NCT06561386 · 2024-10-07 · 1 site observation
RECRUITING
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular DysfunctionNCT06620705 · 2024-09-10 · 1 site observation
RECRUITING
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)NCT06312137 · 2024-04-03 · 1 site observation
RECRUITING
Non-Invasive Portal and Hepatic Vein Pressure EstimationNCT06210178 · 2023-12-01 · 1 site observation
RECRUITING
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryNCT06932081 · 2023-01-01 · 1 site observation
RECRUITING
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPCNCT05393791 · 2022-11-10 · 1 site observation
RECRUITING
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib BloodlevelsNCT05525338 · 2022-03-23 · 1 site observation
RECRUITING
PSMA-PET Guided Hypofractionated Salvage Prostate Bed RadiotherapyNCT04642027 · 2020-09-01 · 1 site observation
RECRUITING
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) TestNCT06193525 · 2019-09-16 · 1 site observation
RECRUITING
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart DiseaseNCT06969924 · 2014-01-01 · 1 site observation
RECRUITING
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNCT07128199 · 2025-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
An Ascending Dose Study of PIT565 in Participants With Rheumatoid ArthritisNCT07029555 · 2025-06-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisNCT06025578 · 2023-10-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical StimulationNCT05814614 · 2023-09-25 · 1 site observation
UNKNOWN
Effectiviteit en Beleving Van FooDIYouNCT06547983 · 2023-08-25 · 1 site observation
COMPLETED
Arginine-stimulated Indication of Early Outcome After Islet TransplantationNCT05540197 · 2023-02-23 · 1 site observation
UNKNOWN
Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's DiseaseNCT05551377 · 2023-01-18 · 1 site observation
UNKNOWN
MAD Study of NX210cNCT05827653 · 2022-12-05 · 1 site observation
COMPLETED
Digitally Supported Self-management Program for Patients With Asthma in Secondary Care: a Pilot StudyNCT05643183 · 2022-11-21 · 1 site observation
COMPLETED
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid ArthritisNCT05502731 · 2022-10-01 · 1 site observation
UNKNOWN
The Stroke Box: a Patient-centered eHealth Approach for Improving Post-stroke Care.NCT05388578 · 2022-07-07 · 1 site observation
UNKNOWN
Clinical Outcome After Total Pancreatectomy With Islet AutotransplantationNCT05287737 · 2022-06-21 · 1 site observation
ENROLLING_BY_INVITATION
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)NCT05173987 · 2022-02-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).NCT05116189 · 2021-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Carotid Body Function in Type 2 Diabetes MellitusNCT05237076 · 2021-12-01 · 1 site observation
COMPLETED
TEIPP Immunotherapy in Patients With NSCLCNCT05898763 · 2021-09-29 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)NCT04895358 · 2021-06-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet TransplantationNCT03867851 · 2021-02-08 · 1 site observation
TERMINATED
SGM-101 in Colorectal Lung MetastasesNCT04737213 · 2020-11-01 · 1 site observation
UNKNOWN
Reduced Anticoagulation Targets in ECLS (RATE)NCT04536272 · 2020-10-01 · 1 site observation
COMPLETED
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)NCT04246177 · 2020-05-22 · 1 site observation
TERMINATED
COVID-19 Glycemic Control StudyNCT05977205 · 2020-05-02 · 1 site observation
COMPLETED
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapyNCT04302454 · 2020-03-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate DNL151 in Subjects With Parkinson's DiseaseNCT04056689 · 2019-07-23 · 1 site observation
COMPLETED
Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure PatientsNCT03575533 · 2019-01-01 · 1 site observation
UNKNOWN
"POWER2DM Evaluation Campaign"NCT03588104 · 2018-12-03 · 1 site observation
COMPLETED
Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 DiabetesNCT03811587 · 2018-11-05 · 1 site observation
COMPLETED
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High CholesterolNCT03060577 · 2017-04-27 · 1 site observation
COMPLETED
A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With ArthritisNCT02727764 · 2017-04-20 · 1 site observation
UNKNOWN
Exenatide and Brown Adipose TissueNCT03002675 · 2016-08-01 · 1 site observation
UNKNOWN
Mirabegron and Brown Adipose TissueNCT03012113 · 2016-06-01 · 1 site observation
UNKNOWN
Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese PatientsNCT02553629 · 2015-09-01 · 1 site observation
COMPLETED
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast CancerNCT02126449 · 2014-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.